IDEXX Laboratories Free Cash Flow 2010-2025 | IDXX

IDEXX Laboratories annual/quarterly free cash flow history and growth rate from 2010 to 2025. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
  • IDEXX Laboratories free cash flow for the quarter ending March 31, 2025 was 808.08, a year-over-year.
  • IDEXX Laboratories free cash flow for the twelve months ending March 31, 2025 was , a year-over-year.
  • IDEXX Laboratories annual free cash flow for 2024 was $0.808B, a 4.55% increase from 2023.
  • IDEXX Laboratories annual free cash flow for 2023 was $0.773B, a 96.09% increase from 2022.
  • IDEXX Laboratories annual free cash flow for 2022 was $0.394B, a 38.03% decline from 2021.
IDEXX Laboratories Annual Free Cash Flow
2024 808.08
2023 772.88
2022 394.15
2021 636.00
2020 541.11
2019 304.19
2018 284.33
2017 298.89
2016 274.16
2015 138.88
2014 180.72
2013 168.38
2012 164.84
2011 168.46
2010 140.04
2009 126.37
IDEXX Laboratories Quarterly Free Cash Flow
2024-12-31 808.08
2024-09-30 575.31
2024-06-30 383.32
2024-03-31 168.31
2023-12-31 772.88
2023-09-30 555.58
2023-06-30 317.25
2023-03-31 144.40
2022-12-31 394.15
2022-09-30 269.95
2022-06-30 118.63
2022-03-31 82.87
2021-12-31 636.00
2021-09-30 457.82
2021-06-30 315.63
2021-03-31 104.26
2020-12-31 541.11
2020-09-30 336.36
2020-06-30 162.46
2020-03-31 -21.13
2019-12-31 304.19
2019-09-30 194.69
2019-06-30 99.49
2019-03-31 -3.83
2018-12-31 284.33
2018-09-30 181.79
2018-06-30 102.35
2018-03-31 11.17
2017-12-31 298.89
2017-09-30 197.78
2017-06-30 102.90
2017-03-31 7.63
2016-12-31 274.16
2016-09-30 188.23
2016-06-30 100.01
2016-03-31 5.08
2015-12-31 138.88
2015-09-30 74.95
2015-06-30 18.65
2015-03-31 -37.66
2014-12-31 180.72
2014-09-30 166.04
2014-06-30 89.87
2014-03-31 22.22
2013-12-31 168.38
2013-09-30 119.12
2013-06-30 56.30
2013-03-31 0.92
2012-12-31 164.84
2012-09-30 110.30
2012-06-30 54.54
2012-03-31 5.74
2011-12-31 168.46
2011-09-30 123.81
2011-06-30 62.36
2011-03-31 15.73
2010-12-31 140.04
2010-09-30 101.42
2010-06-30 57.71
2010-03-31 10.76
2009-12-31 126.37
2009-09-30 81.20
2009-06-30 50.60
2009-03-31 4.56
Sector Industry Market Cap Revenue
Medical MED INSTRUMENTS $38.242B $3.898B
IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) US $189.754B 83.11
Thermo Fisher Scientific (TMO) US $159.887B 19.34
Alcon (ALC) CH $48.486B 32.23
Edwards Lifesciences (EW) US $44.472B 29.10
DexCom (DXCM) US $32.004B 49.47
IQVIA Holdings (IQV) US $27.061B 14.97
Mettler-Toledo (MTD) US $22.925B 27.19
STERIS (STE) IE $22.088B 25.26
Waters (WAT) US $20.850B 29.52
SONOVA HOLDING (SONVY) CH $18.568B 0.00
Hologic (HOLX) US $12.153B 13.11
Sysmex ADR (SSMXY) JP $11.545B 0.00
Penumbra (PEN) US $11.463B 89.97
Globus Medical (GMED) US $9.891B 22.90
Masimo (MASI) US $8.993B 37.74
Teleflex (TFX) US $5.861B 9.22
Glaukos (GKOS) US $5.001B 0.00
Integer Holdings (ITGR) US $4.385B 22.97
PROCEPT BioRobotics (PRCT) US $3.077B 0.00
TransMedics (TMDX) US $3.043B 89.09
Veracyte (VCYT) US $2.377B 42.75
Nihon Kohden (NHNKY) JP $2.113B 11.55
LivaNova (LIVN) GB $2.005B 12.14
Elekta AB (EKTAY) SE $1.960B 17.62
Alphatec Holdings (ATEC) US $1.753B 0.00
Tandem Diabetes Care (TNDM) US $1.431B 0.00
Integra LifeSciences Holdings (IART) US $1.302B 6.58
Pulse Biosciences (PLSE) US $1.156B 0.00
Artivion (AORT) US $0.996B 93.32
OPKO Health (OPK) US $0.930B 0.00
AxoGen (AXGN) US $0.780B 0.00
IRadimed (IRMD) US $0.680B 35.65
Mesa Laboratories (MLAB) US $0.647B 14.14
RxSight (RXST) US $0.644B 0.00
SiBone (SIBN) US $0.595B 0.00
AVANOS MEDICAL, INC (AVNS) US $0.565B 9.10
ORTHOFIX MEDICAL INC (OFIX) US $0.538B 0.00
OrthoPediatrics (KIDS) US $0.520B 0.00
Beta Bionics (BBNX) US $0.513B 0.00
Treace Medical Concepts (TMCI) US $0.457B 0.00
Delcath Systems (DCTH) US $0.415B 0.00
ClearPoint Neuro (CLPT) US $0.404B 0.00
NeuroPace (NPCE) US $0.392B 0.00
AngioDynamics (ANGO) US $0.377B 0.00
Semler Scientific (SMLR) US $0.347B 7.36
Pacific Biosciences Of California (PACB) US $0.339B 0.00
Tactile Systems Technology (TCMD) US $0.333B 17.82
Neuronetics (STIM) US $0.301B 0.00
CVRx (CVRX) US $0.207B 0.00
908 Devices (MASS) US $0.200B 0.00
Inogen (INGN) US $0.194B 0.00
Alpha Tau Medical (DRTS) IL $0.183B 0.00
LENSAR (LNSR) US $0.165B 0.00
Spectral Diagnostics (EDTXF) CA $0.163B 0.00
Anteris Technologies Global (AVR) AU $0.160B 0.00
Sight Sciences (SGHT) US $0.158B 0.00
Accuray (ARAY) US $0.140B 0.00
Lucid Diagnostics (LUCD) US $0.135B 0.00
KORU Medical Systems (KRMD) US $0.132B 0.00
Atossa Genetics (ATOS) US $0.110B 0.00
Rapid Micro Biosystems (RPID) US $0.102B 0.00
Monogram Orthopaedics (MGRM) US $0.102B 0.00
Microbot Medical (MBOT) US $0.083B 0.00
InspireMD (NSPR) IL $0.083B 0.00
EDAP TMS S.A (EDAP) FR $0.082B 0.00
Sensus Healthcare (SRTS) US $0.071B 10.82
EnVVeno Medical (NVNO) US $0.062B 0.00
Hyperfine (HYPR) US $0.054B 0.00
Zomedica (ZOMDF) US $0.052B 0.00
Positron (POSC) US $0.050B 0.00
Vicarious Surgical (RBOT) US $0.049B 0.00
Baird Medical Investment Holdings (BDMD) $0.036B 0.00
Biosig Technologies (BSGM) US $0.033B 0.00
Precision Optics (POCI) US $0.032B 0.00
Spectral AI (MDAI) US $0.032B 0.00
DarioHealth (DRIO) US $0.031B 0.00
Envoy Medical (COCH) US $0.029B 0.00
NexGel (NXGL) US $0.020B 0.00
Adagio Medical Holdings (ADGM) US $0.019B 0.00
Ekso Bionics Holdings (EKSO) US $0.014B 0.00
PAVmed (PAVM) US $0.014B 0.00
Accelerate Diagnostics (AXDX) US $0.013B 0.00
Inspira Technologies OXY B.H.N (IINN) IL $0.008B 0.00
Tenon Medical (TNON) US $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) US $0.007B 0.00
WORK Medical Technology Group (WOK) CN $0.007B 0.00
Autonomix Medical (AMIX) US $0.005B 0.00
ReShape Lifesciences (RSLS) US $0.005B 0.00
Nuwellis (NUWE) US $0.005B 0.00
Check-Cap (CHEK) IL $0.004B 0.00
Nanovibronix (NAOV) US $0.004B 0.00
Venus Concept (VERO) CA $0.004B 0.00
ENDRA Life Sciences (NDRA) US $0.003B 0.00
Helius Medical Technologies (HSDT) US $0.002B 0.00
Avinger (AVGR) US $0.002B 0.00
Bluejay Diagnostics (BJDX) US $0.001B 0.00
Spinal Elements Holdings (SPEL) US $0.000B 0.00
Longview Acquisition II (LGV) US $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) DE $0.000B 15.32